Table 4.

Level of consensus on statements related to treatment safety

Statements	Scores applied, n						Level of consensus, %
	1	2	3	4	5	Total
4.1 Safety should be considered as important as efficacy	0	0	3	3	22	28	100
4.2 Targeted therapies show a very favourable safety profile	0	0	2	13	13	28	100
4.3 Safety should be assessed periodically, according to the patient’s and drug’s characteristics	0	0	2	7	19	28	100